"Nesteroidn\u00ED antiflogistika - me\u010D s dvoj\u00EDm ost\u0159\u00EDm - koment\u00E1\u0159"@cs . "Nesteroidn\u00ED antiflogistika (NSA) jsou velmi d\u016Fle\u017Eitou skupinou l\u00E9\u010Div. Jednak z\u00E1sadn\u00EDm zp\u016Fsobem zlep\u0161uj\u00ED kvalitu \u017Eivota a zlep\u0161uj\u00ED pr\u016Fb\u011Bh v\u011Bt\u0161iny bolestiv\u00FDch a z\u00E1n\u011Btliv\u00FDch stav\u016F postihuj\u00EDc\u00EDch zejm\u00E9na pohybov\u00E9 \u00FAstroj\u00ED, jednak kyselina acetylsalicylov\u00E1 zlep\u0161uje tak\u00E9 progn\u00F3zu nemocn\u00FDch s aterotrombotick\u00FDm posti\u017Een\u00EDm. Bohu\u017Eel je to ale i skupina velmi problematick\u00E1, kter\u00E1 je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou hospitalizac\u00ED pro ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky l\u00E9k\u016F. Z \u0159ady studi\u00ED vypl\u00FDv\u00E1, \u017Ee r\u016Fzn\u00E9 skupiny populace jsou r\u016Fzn\u00FDmi typy ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ohro\u017Eov\u00E1ny odli\u0161n\u011B. V\u00FDb\u011Br optim\u00E1ln\u00EDho l\u00E9ku by m\u011Bl proto zv\u00E1\u017Eit individu\u00E1ln\u00ED podm\u00EDnky pro konkr\u00E9tn\u00EDho nemocn\u00E9ho tak, abychom se vyhnuli Scylle krv\u00E1cen\u00ED do tr\u00E1vic\u00EDho traktu i Charybd\u011B reprezentovan\u00E9 aterotrombotick\u00FDmi komplikacemi." . . . "Nesteroidn\u00ED antiflogistika - me\u010D s dvoj\u00EDm ost\u0159\u00EDm - koment\u00E1\u0159" . "1212-9445" . . "274451" . "RIV/00216208:11120/10:00002703!RIV11-MSM-11120___" . "1"^^ . "CZ - \u010Cesk\u00E1 republika" . . "Nonsteroidal anti-inflammatory drugs (NSAIDs) are a very important group of drugs. First, significantly improving the quality of life and improve the course and the most painful inflammatory condition affecting mainly the motor system, both aspirin improves the prognosis of patients with atherothrombotic disabilities. Unfortunately, it is also very problematic group, the most common cause of hospital admissions for adverse drug effects. A number of studies suggest that different populations are different types of adverse events threatened differently. Selection of optimal drug should therefore consider the individual conditions for a particular patient so as to avoid the Scylla of bleeding in the gastrointestinal tract and the Charybdis represented atherothrombotic complications."@en . . . . "[8FC59654DD0C]" . . . "3" . . "Nonsteroid antiphlogistics - the doubleedge sword"@en . "3"^^ . "11" . "11120" . "Medic\u00EDna po promoci" . . "Nesteroidn\u00ED antiflogistika - me\u010D s dvoj\u00EDm ost\u0159\u00EDm - koment\u00E1\u0159"@cs . "Bultas, Jan" . . . "Nonsteroid antiphlogistics"@en . "Nesteroidn\u00ED antiflogistika (NSA) jsou velmi d\u016Fle\u017Eitou skupinou l\u00E9\u010Div. Jednak z\u00E1sadn\u00EDm zp\u016Fsobem zlep\u0161uj\u00ED kvalitu \u017Eivota a zlep\u0161uj\u00ED pr\u016Fb\u011Bh v\u011Bt\u0161iny bolestiv\u00FDch a z\u00E1n\u011Btliv\u00FDch stav\u016F postihuj\u00EDc\u00EDch zejm\u00E9na pohybov\u00E9 \u00FAstroj\u00ED, jednak kyselina acetylsalicylov\u00E1 zlep\u0161uje tak\u00E9 progn\u00F3zu nemocn\u00FDch s aterotrombotick\u00FDm posti\u017Een\u00EDm. Bohu\u017Eel je to ale i skupina velmi problematick\u00E1, kter\u00E1 je nej\u010Dast\u011Bj\u0161\u00ED p\u0159\u00ED\u010Dinou hospitalizac\u00ED pro ne\u017E\u00E1douc\u00ED \u00FA\u010Dinky l\u00E9k\u016F. Z \u0159ady studi\u00ED vypl\u00FDv\u00E1, \u017Ee r\u016Fzn\u00E9 skupiny populace jsou r\u016Fzn\u00FDmi typy ne\u017E\u00E1douc\u00EDch \u00FA\u010Dink\u016F ohro\u017Eov\u00E1ny odli\u0161n\u011B. V\u00FDb\u011Br optim\u00E1ln\u00EDho l\u00E9ku by m\u011Bl proto zv\u00E1\u017Eit individu\u00E1ln\u00ED podm\u00EDnky pro konkr\u00E9tn\u00EDho nemocn\u00E9ho tak, abychom se vyhnuli Scylle krv\u00E1cen\u00ED do tr\u00E1vic\u00EDho traktu i Charybd\u011B reprezentovan\u00E9 aterotrombotick\u00FDmi komplikacemi."@cs . "1"^^ . "Nesteroidn\u00ED antiflogistika - me\u010D s dvoj\u00EDm ost\u0159\u00EDm - koment\u00E1\u0159" . "Nonsteroid antiphlogistics - the doubleedge sword"@en . "Z(MSM0021620816)" . "RIV/00216208:11120/10:00002703" .